Ryan D. Zubricky
Ophthalmology
1 Ford Pl
Detroit, MI 48202
Detroit, MI 48202
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 27, 2023
Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab.
Journal: Ophthalmology and therapy
Published: April 04, 2023
LASIK Flap Dislocation Masquerading as Corneal Abrasion: Lessons and Pearls.
Journal: The Journal of emergency medicine
Published: February 27, 2023
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration.
Journal: International journal of retina and vitreous
Published: October 17, 2022
Comparison of Face-down Positioning Durations Following Silicone Oil Tamponade.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: May 16, 2022
Showing 1-6 of 6
Last Updated: 09/26/2026